Kendrion N.V [KENDR] vs Wolters Kluwer N.V [WKL] Detailed Stock Comparison
Kendrion N.V
Euronext
Loading...
Wolters Kluwer N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kendrion N.V wins in 8 metrics, Wolters Kluwer N.V wins in 11 metrics, with 0 ties. Wolters Kluwer N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kendrion N.V | Wolters Kluwer N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.88 | 24.96 | Wolters Kluwer N.V |
| Price-to-Book Ratio | 1.09 | 30.99 | Kendrion N.V |
| Debt-to-Equity Ratio | 65.75 | 591.55 | Kendrion N.V |
| PEG Ratio | 9.34 | 22.00 | Kendrion N.V |
| EV/EBITDA | 8.18 | 16.94 | Kendrion N.V |
| Profit Margin (TTM) | -1.30% | 18.48% | Wolters Kluwer N.V |
| Operating Margin (TTM) | 7.55% | 25.66% | Wolters Kluwer N.V |
| EBITDA Margin (TTM) | 7.55% | 25.66% | Wolters Kluwer N.V |
| Return on Equity | 2.98% | 92.62% | Wolters Kluwer N.V |
| Return on Assets (TTM) | 2.62% | 10.34% | Wolters Kluwer N.V |
| Free Cash Flow (TTM) | $-5.10M | $1.34B | Wolters Kluwer N.V |
| Dividend Yield | 3.95% | 1.63% | Kendrion N.V |
| 1-Year Return | -8.29% | -20.64% | Kendrion N.V |
| Price-to-Sales Ratio (TTM) | 0.55 | 4.50 | Kendrion N.V |
| Enterprise Value | $266.60M | $33.04B | Wolters Kluwer N.V |
| EV/Revenue Ratio | 0.87 | 5.44 | Kendrion N.V |
| Gross Profit Margin (TTM) | 50.58% | N/A | N/A |
| Revenue per Share (TTM) | $20 | $26 | Wolters Kluwer N.V |
| Earnings per Share (Diluted) | $0.32 | $4.76 | Wolters Kluwer N.V |
| Beta (Stock Volatility) | 0.80 | 0.26 | Wolters Kluwer N.V |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kendrion N.V vs Wolters Kluwer N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kendrion N.V | 4.34% | 4.14% | -1.07% | 3.17% | 8.01% | 6.14% |
| Wolters Kluwer N.V | -4.35% | -10.74% | -14.69% | -25.24% | -33.59% | -26.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kendrion N.V | -8.29% | -27.81% | -9.64% | -58.87% | 10.60% | -34.94% |
| Wolters Kluwer N.V | -20.64% | 14.23% | 70.84% | 302.58% | 685.71% | 672.93% |
Performance & Financial Health Analysis: Kendrion N.V vs Wolters Kluwer N.V
| Metric | KENDR | WKL |
|---|---|---|
| Market Information | ||
| Market Cap | €168.02M | €27.35B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 7,987 | 788,601 |
| 90 Day Avg. Volume | 15,789 | 624,610 |
| Last Close | €11.06 | €118.80 |
| 52 Week Range | €9.11 - €13.48 | €118.35 - €181.30 |
| % from 52W High | -17.95% | -34.47% |
| All-Time High | €409.39 (Oct 21, 2002) | €181.30 (Feb 10, 2025) |
| % from All-Time High | -97.30% | -34.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.06% |
| Quarterly Earnings Growth | 0.19% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.18% |
| Operating Margin (TTM) | 0.08% | 0.26% |
| Return on Equity (TTM) | 0.03% | 0.93% |
| Debt to Equity (MRQ) | 65.75 | 591.55 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €9.96 | €3.83 |
| Cash per Share (MRQ) | €0.49 | €4.07 |
| Operating Cash Flow (TTM) | €-13,800,000 | €1.70B |
| Levered Free Cash Flow (TTM) | €-4,500,000 | €1.02B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.95% | 1.63% |
| Last 12-Month Dividend | €0.45 | €2.33 |
Valuation & Enterprise Metrics Analysis: Kendrion N.V vs Wolters Kluwer N.V
| Metric | KENDR | WKL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.88 | 24.96 |
| Forward P/E | 9.34 | 22.00 |
| PEG Ratio | 9.34 | 22.00 |
| Price to Sales (TTM) | 0.55 | 4.50 |
| Price to Book (MRQ) | 1.09 | 30.99 |
| Market Capitalization | ||
| Market Capitalization | €168.02M | €27.35B |
| Enterprise Value | €266.60M | €33.04B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.87 | 5.44 |
| Enterprise to EBITDA | 8.18 | 16.94 |
| Risk & Other Metrics | ||
| Beta | 0.80 | 0.26 |
| Book Value per Share (MRQ) | €9.96 | €3.83 |
Financial Statements Comparison: Kendrion N.V vs Wolters Kluwer N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KENDR | WKL |
|---|---|---|
| Revenue/Sales | €78.10M | N/A |
| Cost of Goods Sold | €38.60M | N/A |
| Gross Profit | €39.50M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | €4.60M | N/A |
| EBITDA | €10.40M | N/A |
| Pre-Tax Income | €4.40M | N/A |
| Income Tax | €1.30M | N/A |
| Net Income (Profit) | €3.20M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KENDR | WKL |
|---|---|---|
| Cash & Equivalents | €7.80M | €954.00M |
| Total Current Assets | €121.90M | €2.66B |
| Total Current Liabilities | €74.70M | €3.78B |
| Long-Term Debt | €93.30M | €3.65B |
| Total Shareholders Equity | €159.40M | €1.55B |
| Retained Earnings | €3.20M | N/A |
| Property, Plant & Equipment | N/A | €293.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KENDR | WKL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KENDR | WKL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 7,987 | 788,601 |
| Average Daily Volume (90 Day) | 15,789 | 624,610 |
| Shares Outstanding | 15.50M | 234.30M |
| Float Shares | 12.17M | 231.30M |
| % Held by Insiders | 0.09% | 0.00% |
| % Held by Institutions | 0.49% | 0.67% |
Dividend Analysis & Yield Comparison: Kendrion N.V vs Wolters Kluwer N.V
| Metric | KENDR | WKL |
|---|---|---|
| Last 12-Month Dividend | €0.45 | €2.33 |
| Last 12-Month Dividend Yield | 3.95% | 1.63% |
| 3-Year Avg Annual Dividend | €0.54 | €2.07 |
| 3-Year Avg Dividend Yield | 4.02% | 0.80% |
| 3-Year Total Dividends | €1.62 | €6.22 |
| Ex-Dividend Date | Apr 16, 2025 | May 19, 2025 |